Afatinib free base
Afatinib, also known as BIBW 2992, is an orally bioavailable dual receptor tyrosine kinase (RTK) inhibitor with potential antitumor activity. BIBW 2992 irreversibly binds and inhibits human EGFR-1 and HER2, thereby potentially inhibiting tumor growth and angiogenesis.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0372 |
| Pricing | 100.0 mg, 200.0 mg, 500.0 mg, 1.0 g, 2.0 g, 5.0 g, inquire |